1. Necroptosis: A new way of dying?
   Britt Hanson, 2016, Cancer Biology & Therapy CrossRef
2. Shikonin Inhibits the Migration and Invasion of Human Glioblastoma Cells by Targeting Phosphorylated β-Catenin and Phosphorylated PI3K/Akt: A Potential Mechanism for the Anti-Glioma Efficacy of a Traditional Chinese Herbal Medicine
   Feng-Ying Zhang et al, 2015, IJMS CrossRef
3. Targeted knockdown of DJ-1 induces multiple myeloma cell death via KLF6 upregulation
   Prahlad V. Raninga et al, 2016, Apoptosis CrossRef
4. Shikonin induces necroptosis by reactive oxygen species activation in nasopharyngeal carcinoma cell line CNE-2Z
   Zixuan Zhang et al, 2017, J Bioenerg Biomembr CrossRef
5. Shikonin inhibits inflammation and chondrocyte apoptosis by regulation of the PI3K/Akt signaling pathway in a rat model of osteoarthritis
   Daijie Fu et al, 2016 CrossRef
6. Shikonin induces glioma cell necroptosis in vitro by ROS overproduction and promoting RIP1/RIP3 necrosome formation.
   Bin Lu et al, 2017, Acta Pharmacol Sin CrossRef
7. Necroptosis promotes autophagy-dependent upregulation of DAMP and results in immunosurveillance
   Sheng-Yen Lin et al, 2017, Autophagy CrossRef
8. Non-apoptotic Cell Death in Malignant Tumor Cells and Natural Compounds
   Jing Ye et al, 2018, Cancer Letters CrossRef
9. Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis
   Kelby W. Wegner et al, 2017, Trends in Pharmacological Sciences CrossRef
10. RIP1 and RIP3 contribute to shikonin-induced glycolysis suppression in glioma cells via increase of intracellular hydrogen peroxide
    Bin Lu et al, 2018, Cancer Letters CrossRef
11. null
    Francis Ka-Ming Chan et al, 2019 CrossRef
12. null
    Walter Gottlieb Land, 2018 CrossRef
13. Bulnesia sarmientoi Supercritical Fluid Extract Exhibits Necroptotic Effects and Anti-Metastatic Activity on Lung Cancer Cells
    Heng-Long Wang et al, 2018, Molecules CrossRef
14. Inhibition of lung cancer by 2-methoxy-6-acetyl-7-methyljuglone (MAM) through induction of necroptosis by targeting receptor-interacting protein 1 (RIP1)
    Wen Sun et al, 2018, Antioxidants & Redox Signaling CrossRef
15. Shikonin inhibits cancer cell cycling by targeting Cdc25s
    Shoude Zhang et al, 2019, BMC Cancer CrossRef
16. Redox biology of regulated cell death in cancer: A focus on necroptosis and ferroptosis.
    Marc Diederich, 0 CrossRef
17. A new pyridazinone exhibits potent cytotoxicity on human cancer cells via apoptosis and poly-ubiquitinated protein accumulation
    Denisse A. Gutierrez et al, 2019, Cell Biol Toxicol CrossRef
18. Exploiting Necroptosis for Therapy of Acute Lymphoblastic Leukemia
    Caterina Mezzatesta et al, 2019, Front. Cell Dev. Biol. CrossRef
19. Shikonin derivatives for cancer prevention and therapy.
    Joelle C Boulos et al, 2019, Cancer Lett CrossRef
20. Cancer and necroptosis: friend or foe?
    Stephan Philipp et al, 2016, Cell. Mol. Life Sci. CrossRef
21. RIP1 and RIP3 contribute to shikonin-induced DNA double-strand breaks in glioma cells via increase of intracellular reactive oxygen species.
    Zijian Zhou et al, 0 CrossRef
22. Enhancement of NK cells proliferation and function by Shikonin.
    Yan Li et al, 2017, Immunopharmacol Immunotoxicol CrossRef
23. Shikonin alleviates the biotoxicity produced by pneumococcal pneumolysin
    Xiaoran Zhao et al, 2017, Life Sciences CrossRef
24. Pharmacological properties and derivatives of shikonin-A review in recent years.
    Chuanjie Guo et al, 2019, Pharmacol Res CrossRef
25. MLKL contributes to shikonin-induced glioma cell necroptosis via promotion of chromatinolysis
    Ye Ding et al, 2019, Cancer Letters CrossRef
26. Cell death mechanisms in eukaryotes.
    J Grace Nirmala et al, 2020, Cell Biol Toxicol CrossRef
27. Jujuboside B promotes the death of acute leukemia cell in a RIPK1/RIPK3/MLKL pathway-dependent manner.
    Miao-Miao Jia et al, 2020, Eur J Pharmacol CrossRef
28. 11-Methoxytabersonine Induces Necroptosis with Autophagy through AMPK/mTOR and JNK Pathways in Human Lung Cancer Cells
    Di Ge et al, 2020, Chem. Pharm. Bull. CrossRef
29. Phytochemical-Mediated Glioma Targeted Treatment: Drug Resistance and Novel Delivery Systems
    Hang Cao et al, 2020, CMC CrossRef
30. Cell apoptosis, autophagy and necroptosis in osteosarcoma treatment
    Jing Li et al, 2016, Oncotarget CrossRef
31. Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy
    Mao-Bin Meng et al, 2016, Oncotarget CrossRef
32. The TAT-RasGAP317-326 anti-cancer peptide can kill in a caspase-, apoptosis-, and necroptosis-independent manner
    Mathieu Heulot et al, 2016, Oncotarget CrossRef
33. Inhibition of c-MYC with involvement of ERK/JNK/MAPK and AKT pathways as a novel mechanism for shikonin and its derivatives in killing leukemia cells
    Qiaoli Zhao et al, 2015, Oncotarget CrossRef
34. Induction of programmed necrosis: A novel anti-cancer strategy for natural compounds
    Jie Yu et al, 2020, Pharmacology & Therapeutics CrossRef
35. null
    Jie Yu et al, 2020 CrossRef
36. Label-Free Classification of Apoptosis, Ferroptosis and Necroptosis Using Digital Holographic Cytometry
    Kendra L. Barker et al, 2020, Applied Sciences CrossRef
37. Necroptosis: A novel manner of cell death, associated with stroke (Review)
    Chenglin Liu et al, 2017, Int J Mol Med CrossRef
38. The Role of Necroptosis in ROS-Mediated Cancer Therapies and Its Promising Applications
    Sheng-Kai Hsu et al, 2020, Cancers CrossRef
39. Shikonin overcomes drug resistance and induces necroptosis by regulating the miR-92a-1-5p/MLKL axis in chronic myeloid leukemia
    Xianbo Huang et al, 2020, Aging CrossRef
40. Natural product scaffolds as inspiration for the design and synthesis of 20S human proteasome inhibitors
    Grace E. Hubbell et al, 2020, RSC Chem. Biol. CrossRef
41. Induction of apoptosis by Shikonin through ROS-mediated intrinsic and extrinsic apoptotic pathways in primary effusion lymphoma
    Md Masud Alam et al, 2021, Translational Oncology CrossRef
42. Natural Products as Inducers of Non-Canonical Cell Death: A Weapon against Cancer
    Giulia Greco et al, 2021, Cancers CrossRef
43. Caspase-Independent Regulated Necrosis Pathways as Potential Targets in Cancer Management
    Jianyao Lou et al, 2021, Front. Oncol. CrossRef
44. Targeting Drug Chemo-Resistance in Cancer Using Natural Products.
    Wamidh H Talib et al, 2021, Biomedicines CrossRef
45. Molecular mechanism of shikonin inhibiting tumor growth and potential application in cancer treatment
    Qiang Wang et al, 2021 CrossRef
46. Shikonin Inhibits Cell Growth of Sunitinib-Resistant Renal Cell Carcinoma by Activating the Necrosome Complex and Inhibiting the AKT/mTOR Signaling Pathway
    Sascha D. Markowitsch et al, 2022, Cancers CrossRef
47. Systematic Screening of Chemical Constituents in the Traditional Chinese Medicine Arnebiae Radix by UHPLC-Q-Exactive Orbitrap Mass Spectrometry
    Lian Zhu et al, 2022, Molecules CrossRef
48. Anti-cancer Research on Arnebiae radix-derived Naphthoquinone in Recent Five Years
    Lian Zhu et al, 2022, PRA CrossRef
49. Mechanism of Bile Acid-Induced Programmed Cell Death and Drug Discovery against Cancer: A Review
    Jung Yoon Jang et al, 2022, IJMS CrossRef
50. Shikonin induces ferroptosis in multiple myeloma via GOT1-mediated ferritinophagy
    Wenxia Li et al, 2022, Front. Oncol. CrossRef
51. Necroptosis: A Pathogenic Negotiator in Human Diseases
    Hitesh Singh Chaouhan et al, 2022, IJMS CrossRef
52. Mode of Actions of Bile Acids in Avoidance of Colorectal Cancer Development; and their Therapeutic Applications in Cancers - A Narrative Review
    Kulvinder Kochar Kaur et al, 2022, J. Pharm. Nutr. Sci. CrossRef
53. Synthetic Small Molecule Modulators of Hsp70 and Hsp40 Chaperones as Promising Anticancer Agents
    Bianca Nitzsche et al, 2023, IJMS CrossRef